Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
about
New approaches to understanding the immune response to vaccination and infectionImmune response to vaccine adjuvants during the first year of lifeHypothesis driven development of new adjuvants: short peptides as immunomodulatorsRationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvantsEarly Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human PrimatesTargeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective ImmunityPolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In VivoSystems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivityInterferons and viruses: an evolutionary arms race of molecular interactionsHuman genome-wide RNAi screen identifies an essential role for inositol pyrophosphates in Type-I interferon responseInfluenza vaccines: a moving interdisciplinary field.Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines.Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation.Harnessing Human Cross-Presenting CLEC9A(+)XCR1(+) Dendritic Cells for Immunotherapy.Modulation of innate immune signaling by the secreted form of the West Nile virus NS1 glycoproteinVaccine strategies utilizing C-type lectin receptors on dendritic cells in vivoSelection of Reference Genes for Gene Expression Studies in Porcine Whole Blood and Peripheral Blood Mononuclear Cells under Polyinosinic:Polycytidylic Acid Stimulation.Combination GITR targeting/PD-1 blockade with vaccination drives robust antigen-specific antitumor immunity.Coadministration of polyinosinic:polycytidylic acid and immunostimulatory complexes modifies antigen processing in dendritic cell subsets and enhances HIV gag-specific T cell immunity.Activated iNKT cells promote memory CD8+ T cell differentiation during viral infectionmTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function.Intranasal administration of dsRNA analog poly(I:C) induces interferon-α receptor-dependent accumulation of antigen experienced T cells in the airways.Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant.Clinical adjuvant combinations stimulate potent B-cell responses in vitro by activating dermal dendritic cellsNovel drugs targeting Toll-like receptors for antiviral therapy.Pediatric phase II trials of poly-ICLC in the management of newly diagnosed and recurrent brain tumors.Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling.Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins.Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunityType I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis.Inactivated Eyedrop Influenza Vaccine Adjuvanted with Poly(I:C) Is Safe and Effective for Inducing Protective Systemic and Mucosal Immunity.Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants.Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicityTLR3-Induced Maturation of Murine Dendritic Cells Regulates CTL Responses by Modulating PD-L1 Trafficking.Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice.Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:CHuman papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:C.Intranasal treatment with poly(I•C) protects aged mice from lethal respiratory virus infections.TLR3/TICAM-1 signaling in tumor cell RIP3-dependent necroptosis
P2860
Q26800283-A3F2487B-0E2B-4EF0-AD7D-9E19AC573861Q27016633-54295B30-237C-4093-93F1-51199D85B0A2Q27023844-BAE2B128-A19D-445A-B0A3-1D950BCF591FQ27025822-D096354C-B2E7-4143-A1BE-483418CE0214Q27303669-12D52DB4-8EDE-485D-8402-9B5DAA0A467FQ27312070-B75FD2BB-8118-4DC1-ABC2-B0E36E9839A2Q27324710-66DC245F-7619-4D59-8524-57566E443601Q27335125-D1D35073-B71F-48C4-A7F7-1A63D7850565Q28083788-F04DF2C1-91C1-4693-B649-E1A879DA71C6Q28540195-6D73C58E-13C0-4E09-9E7F-C02AC0E12E2AQ30367695-BCDBA1D7-251E-44B1-8C04-5093F51CC120Q30540603-48C6856D-03E8-44DC-B40B-8C9C03447FE6Q31152190-03B0F9A4-7AF9-40E3-B44E-DE5CE32EDB58Q33659782-D4110A46-BCE3-4F6A-8D66-9075B79F82C3Q33821633-21B0F911-9CBE-47B7-B20A-80A33D36993CQ33850483-D82E4A03-08A9-4A90-9339-8DA4EE0C8D6DQ33886345-54FFBDF2-9E2A-40F8-8F39-552C8C78DA41Q33889105-30368AF9-7A33-4636-93B6-28F728167DEEQ33909362-165ACEC5-ABAA-42F9-8C47-6D67B37543C4Q34287659-A90CC18C-25EE-46B7-BB0A-E7EB96F33E8AQ34364808-490A7287-F124-46AC-A0EB-45B62ACCFE9FQ34510913-B1C2B5BD-D503-4B82-8418-D4EA815603C8Q34540207-662DAC1E-6E91-4242-95BD-AADEEB897E28Q34667534-B9D46113-85B7-463D-8072-4AEEFC3BCCFAQ34735203-4BCBAC6F-DC2E-465D-8182-5CDAF366883DQ34999938-E267247D-EED8-4D17-BF43-4207842E4D3EQ35167156-CB0F0E31-44B7-49B2-990F-A4769FEB0461Q35183935-CC83DEE0-10B0-45BE-9DDB-1F3DACF3202BQ35488175-AEEF8B7C-DADC-4B41-84A0-262259272F17Q35680858-26CEA386-A3D0-4060-902F-D93A3B1642EEQ35739585-5974B91A-1EDA-4B2D-A9C0-EAAFEE347B89Q35768825-9A30292E-1CA0-4C2C-90AB-CDD5F261BD82Q35836140-6CC0F96F-0BE5-4848-81A5-F2234D659B4CQ36016455-B391D292-B52D-4AF1-8AC4-879D2B9B9A85Q36212034-93D06A68-DB47-49BC-B83D-0CB4F51EB0A9Q36245506-DB00DCEC-F861-43B0-9269-9E50950CAD90Q36315857-C69D5A6A-34D2-4EF7-AE4B-109417133DD3Q36350381-4937DBF5-D690-47E8-8422-A44042ED822AQ36363186-62B8FB86-7D26-435C-BDDD-481C75DA3E4EQ36373374-5B826607-7B5D-4144-962D-BAE258F8D1FB
P2860
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Synthetic double-stranded RNA ...... a live viral vaccine in humans
@ast
Synthetic double-stranded RNA ...... a live viral vaccine in humans
@en
type
label
Synthetic double-stranded RNA ...... a live viral vaccine in humans
@ast
Synthetic double-stranded RNA ...... a live viral vaccine in humans
@en
prefLabel
Synthetic double-stranded RNA ...... a live viral vaccine in humans
@ast
Synthetic double-stranded RNA ...... a live viral vaccine in humans
@en
P2093
P2860
P356
P1476
Synthetic double-stranded RNA ...... a live viral vaccine in humans
@en
P2093
Abdelali Filali-Mouhim
Andres M Salazar
Angela Duque-Alarcon
Annette Nelkenbaum
Christine Trumpfheller
Elias K Haddad
François Lefebvre
Gaëlle Breton
Irina Shimeliovich
Jean-Philippe Goulet
P2860
P304
P356
10.1084/JEM.20111171
P407
P577
2011-11-07T00:00:00Z